A detailed history of Black Rock Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,920,538 shares of FLGT stock, worth $79.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,920,538
Previous 3,761,878 4.22%
Holding current value
$79.9 Million
Previous $109 Million 21.77%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$21.55 - $29.29 $3.42 Million - $4.65 Million
158,660 Added 4.22%
3,920,538 $85.1 Million
Q4 2023

Feb 13, 2024

BUY
$23.64 - $30.27 $3.7 Million - $4.73 Million
156,307 Added 4.34%
3,761,878 $109 Million
Q3 2023

Nov 13, 2023

SELL
$26.74 - $40.81 $642,936 - $981,235
-24,044 Reduced 0.66%
3,605,571 $96.4 Million
Q2 2023

Aug 11, 2023

SELL
$28.52 - $40.7 $479,278 - $683,963
-16,805 Reduced 0.46%
3,629,615 $134 Million
Q1 2023

May 12, 2023

BUY
$29.39 - $36.27 $3.49 Million - $4.3 Million
118,638 Added 3.36%
3,646,420 $114 Million
Q4 2022

Feb 13, 2023

BUY
$29.23 - $40.28 $1.27 Million - $1.75 Million
43,443 Added 1.25%
3,527,782 $105 Million
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $5.65 Million - $9.5 Million
149,014 Added 4.47%
3,484,339 $133 Million
Q2 2022

Aug 12, 2022

BUY
$47.98 - $62.75 $1.97 Million - $2.57 Million
40,971 Added 1.24%
3,335,325 $182 Million
Q1 2022

May 12, 2022

SELL
$49.85 - $96.11 $6.33 Million - $12.2 Million
-126,897 Reduced 3.71%
3,294,354 $206 Million
Q4 2021

Feb 10, 2022

BUY
$77.3 - $105.0 $3.92 Million - $5.33 Million
50,770 Added 1.51%
3,421,251 $344 Million
Q3 2021

Nov 09, 2021

BUY
$74.87 - $110.87 $23.4 Million - $34.7 Million
313,166 Added 10.24%
3,370,481 $303 Million
Q2 2021

Aug 11, 2021

BUY
$66.8 - $100.45 $204 Million - $307 Million
3,057,315 New
3,057,315 $282 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $617M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.